SUMMARY Patients with coeliac disease have a greatly enhanced whole body synthesis of cholesterol, but its origin is not known. In this paper the synthesis and concentrations of cholesterol and its precursors, squalene and methyl sterols, were studied in jejunal biolVsies from healthy volunteers and adult patients with coeliac disease. The incorporation rates of C-acetate and 3H-mevalonate into non-saponifiable lipids (sum of squalene, methyl sterols and cholesterol) were increased 14 and six times in the damaged mucosa, respectively. The cyclisation rate of mucosal squalene and the conversion of squalene to cholesterol were also increased, indicating that cholesterol synthesis was activated before mevalonate, probably at the step of HMG-CoA reductase, and also after mevalonate and squalene. The steps from squalene to cholesterol were apparently not rate limiting because the mucosal concentrations and the percentage distribution of squalene and sterols were similar in the patients and in the controls. A positive correlation of the cholesterol synthesis with the number of crypt cells, suggests that the expanded crypt cell population contributed to the enhanced intestinal cholesterologenesis. Furthermore, the serum cholesterol level was negatively correlated with the 14C-and 3H-counts in the mucosal cholesterol and with the cyclisation rate of squalene probable signs of regulatory role of serum low density lipoprotein cholesterol in intestinal cholesterol synthesis. Consequently, provided that the synthesis of musocal cholesterol is as high in vivo as in vitro it could contribute to the highly increased overall synthesis of cholesterol in the patients with coeliac disease.
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Previous studies have shown that the whole body synthesis of cholesterol in patients with coeliac disease is greatly enhanced. The liver and the small intestine are most likely the sites of the increased cholesterol synthesis because available data indicate that these organs have the most active cholesterogenesis in the body.3 4 At present no direct measurements of hepatic cholesterol synthesis exist in coeliac disease. The recent data on lipoprotein metabolism in coeliac disease, however, indicate that the synthesis in the liver may not be markedly increased because the production rates of very low density lipoprotein and low density lipoprotein and the receptor mediated catabolism of low density lipoprotein are low. 
INCUBATIONS
The biopsy specimens of the controls and the patients used for incubation studies weighed 13-0+2-1 mg and 11-5±1-8 mg (mean±SEM), respectively. They were incubated in 2-0 ml KrebsRinger bicarbonate buffer containing 4% bovine albumin (Fraction V, Armour Pharmaceutical Company, England). The pH was adjusted to by gassing the medium continuously with 95% 02 and 5% CO2. After preincubation for five min 6 RCi of both 14C-acetate (specific activity 2-9 mCi/mg) and 3H-mevalonate (specific activity 2-9 mCi/mg) with unlabelled acetate and mevalonate were added into the incubation medium to get a final concentration of 0 5 mmol/ for both substrates. The incubation was continued at 37°C up to three hours with shaking (100 oscillations/min).
CHEMICAL METHODS
After incubation the specimens were washed five times with physiological saline, homogenised and after addition of coprostanol for an internal standard, lipids were extracted with choloroformmethanol (2:1).7 After removal of the lower phase the remainder was evaporated to dryness, dissolved in 0.1 N NaOH and the protein content was determined according to Lowry et al. 8 The lower phase was washed three times with the pure solvent upper phase to remove the non-lipid radioactivity. After evaporation of the choloroform phase with a nitrogen stream, the extract was saponified with 10 N NaOH-absolute ethanol (1:9) for one hour at 80°C. Non-saponifiable lipids were extracted with petroleum ether and analysed with a thin layer chromatographic -gas liquid chromatographic method. was quite similar in the two groups (9*3x 103 vs 9*1 x 103). In the patients, however, the villous height and the number of villous cells were low and the number of crypt cells high, so that the ratio villous cell/crypt cell was markedly lower in the jejunal mucosa from the patients than the controls ( Table 2 ).
The respective radioactivities of '4C and 3H recovered in non-saponifiable lipids (sum of squalene, methyl sterols and cholesterol) after incubation of mucosal biopsies with a mixture of 14C-acetate and 3H-mevalonate were 14 and six times higher in the patients than in the controls (Table 3) . Thus, the mucosal cholesterol synthesis was activated both before and after the mevalonate step in the patients. The cyclisation rate of squalene was four times higher in the patients than in the controls indicating that also the postsqualene steps were enhanced in the damaged mucosa (Table 4) .
The relative distribution of the 14C-and 3H-radioactivities between mucosal squalene, methyl sterols and cholesterol showed that the proportion of the labels remaining in squalene was significantly lower, that in methyl sterols similar and that in cholesterol markedly higher in the patients than in the controls (Table 3 ). In addition, the mucosal precursor concentrations were similar (Table 5) in the two groups. The findings suggest that also the demethylation and double bond rearrangement of lanosterol and other methyl sterols were markedly accelerated in the diseased mucosa. The 14C/3H-ratios in squalene and sterols were, however, only two-fold increased in the patients as compared with the controls (Table 3) . To disclose possible reasons for the increased synthesis activity of cholesterol in the diseased mucosa several correlations were calculated. The proportions of 14C-and 3H-counts in mucosal cholesterol were negatively correlated with the villous cell/crypt cell ratio (r= -0-58; p<005 and Thus, the high synthesis rate of cholesterol is closely related to the increased crypt cell population in the damaged mucosa. The serum cholesterol level was negatively correlated with the proportions of 14C. and 3H-counts in mucosal cholesterol (r= -0-66 and r=-0-57; p<005 for both), and the cyclisation rate of squalene (r=-0.64; p<0-05).
Discussion
The present results show that in the synthesis pathway of cholesterol the steps between acetate and mevalonate, between mevalonate and squalene, and squalene and cholesterol are markedly activated in the damaged jejunal mucosa from patients with coeliac disease. These findings confirm and extend the preliminary observations of enhanced intestinal cholesterol synthesis in coeliac disease. 3 14 The activity of HMG-CoAR (3- provide insufficient cholesterol to hepatocytes and crypt cells enhancing their cholesterol synthesis. In the rat small intestinal epithelium not only the low density lipoprotein-cholesterol uptake and the rate of cholesterol synthesis appear to be separate events,26 but also the regulation of cholesterol synthesis within the two cell types may be different. 22 Although in the present study the activity of intestinal cholesterol synthesis was highly increased in the patients with coeliac disease, cholesterol was not accumulated into the mucosa. Three possibilities can be visualised for this phenomenon. The finding could represent normal cholesterol metabolism in human crypt cells. A rapid enterocyte turnover could increase synthesis and consumption of cholesterol when sloughed cells would increase the loss into the gut. Newly synthesised cholesterol could also be secreted as a constituent of intestinal lipoproteins into the circulation. In coeliac disease the mitotic activity and the cell production rate in jejunal mucosa are actually increased two to six fold. 27 28 Also the previous observations indicate that the faecal excretion of mucosal cholesterol loss from the gut tends to be higher in the patients than in the controls (370 vs 198 mg/day 29). Thus, provided that the synthesis of intestinal cholesterol is increased in coeliac disease as much in vivo as in vitro, a portion of it could be shunted into the circulation to balance for the highly increased biliary secretion of cholesterol in coeliac disease. 
